WINNERS & LOSERS: Time Finance backs buyout; Nostrum sells assets
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More
| Price | 3.69p on 19-08-2026 at 17:45:08 |
|---|---|
| Change | 0.075p 2.07% |
| Buy | 3.65p |
| Sell | 3.40p |
| Last Trade: | Buy 1,349.00 at 3.69p |
| Day's Volume: | 2,132,134 |
| Last Close: | 3.69p |
| Open: | 3.65p |
| ISIN: | GB0033711010 |
| Day's Range | 3.30p - 3.69p |
| 52wk Range: | 1.505p - 19.00p |
| Market Capitalisation: | £23.02m |
| VWAP: | 3.53047p |
| Shares in Issue: | 623.91m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Immupharma (IMM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 1,349 | 3.69p | Suspected BUY Trade |
16:40:36 - 19-Aug-26 |
| Buy* | 20,000 | 3.6129p | Ordinary |
16:25:19 - 19-Aug-26 |
| Buy* | 100,000 | 3.539p | Ordinary |
16:24:30 - 19-Aug-26 |
| Sell* | 38,000 | 3.444p | Ordinary |
16:21:40 - 19-Aug-26 |
| Buy* | 50,000 | 3.49p | Ordinary |
16:16:06 - 19-Aug-26 |
| Buy* | 8,084 | 3.4964p | Ordinary |
16:07:50 - 19-Aug-26 |
| Buy* | 133,543 | 3.4749p | Ordinary |
16:04:07 - 19-Aug-26 |
| Sell* | 50,000 | 3.4246p | Ordinary |
16:01:09 - 19-Aug-26 |
| Sell* | 9,023 | 3.431p | Ordinary |
15:55:43 - 19-Aug-26 |
| Buy* | 200 | 3.50p | SI Trade |
15:47:47 - 19-Aug-26 |
Immupharma (IMM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 10th Aug 2026 7:00 am | RNS | Bioanalytical CRO partner for Kapiglucagon |
| 22nd Jul 2026 7:00 am | RNS | Thermo Fisher CDMO selected for Kapiglucagon pro |
| 25th Jun 2026 1:20 pm | RNS | 2026 RESULT OF ANNUAL GENERAL MEETING |
| 25th Jun 2026 7:00 am | RNS | ImmuPharma appoints Bachem for Kapiglucagon API |
| 24th Jun 2026 7:00 am | RNS-R | University of Murcia research relating to P140 |
| 4th Jun 2026 7:10 am | RNS-R | Incanthera plc – Corporate Update & Board Changes |
| 2nd Jun 2026 7:00 am | RNS | Notice of AGM & Annual Report & Accounts |
| 27th May 2026 7:00 am | RNS | Final Results |
| 5th May 2026 7:00 am | RNS | IMM initiatesIND-Enabling Program for Kapiglucagon |
| 10th Apr 2026 7:00 am | RNS | Holding(s) in Company |